Previous studies reported the presence of anti-SRP or anti-HMGCR antibodies at frequencies of 5–20% in patients with PM and DM, and skin involvement in about 5% of patients with IMNM [7, 10, 13, 30–32]. Here, UCN2 is linked to dermatomyositis.